1. Home
  2. CYTK vs ALLE Comparison

CYTK vs ALLE Comparison

Compare CYTK & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$76.84

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Allegion plc

ALLE

Allegion plc

N/A

Current Price

$168.40

Market Cap

11.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
ALLE
Founded
1997
2013
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
11.7B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
CYTK
ALLE
Price
$76.84
$168.40
Analyst Decision
Strong Buy
Hold
Analyst Count
19
8
Target Price
$89.26
$167.13
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
1.60%
EPS Growth
N/A
9.09
EPS
N/A
3.74
Revenue
$13,368,000.00
N/A
Revenue This Year
$7.37
$8.47
Revenue Next Year
$310.19
$4.58
P/E Ratio
N/A
$44.29
Revenue Growth
N/A
N/A
52 Week Low
$34.60
$125.00
52 Week High
$88.31
$183.11

Technical Indicators

Market Signals
Indicator
CYTK
ALLE
Relative Strength Index (RSI) 45.54 72.87
Support Level $73.95 $162.88
Resistance Level $79.66 $183.11
Average True Range (ATR) 2.91 4.48
MACD -0.37 0.91
Stochastic Oscillator 33.77 88.35

Price Performance

Historical Comparison
CYTK
ALLE

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ALLE Allegion plc

Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.

Share on Social Networks: